Applied Historical Income Statement
| APLT Stock | USD 10.21 0.62 6.47% |
Historical analysis of Applied Therapeutics income statement accounts such as Interest Income of 1.1 M, Discontinued Operations of 0.0 or Interest Expense of 302.3 K can show how well Applied Therapeutics performed in making a profits. Evaluating Applied Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Applied Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Applied Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied Therapeutics is a good buy for the upcoming year.
Applied |
About Applied Income Statement Analysis
Applied Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Applied Therapeutics shareholders. The income statement also shows Applied investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Applied Therapeutics Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Applied Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Net Interest Income is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 21.9 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 66.1 M in 2024.
Applied Therapeutics income statement Correlations
Click cells to compare fundamentals
Applied Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 93K | 559K | 555K | 685K | 1.4M | 1.4M | |
| Interest Expense | 93K | 559K | 555K | 442K | 508.3K | 302.3K | |
| Selling General Administrative | 13.2M | 32.7M | 43.0M | 27.3M | 20.6M | 21.9M | |
| Gross Profit | (23K) | (380K) | (415K) | (441K) | 9.6M | 10.1M | |
| Other Operating Expenses | 45.6M | 94.5M | 105.6M | 83.0M | 74.5M | 66.1M | |
| Operating Income | (45.6M) | (94.5M) | (105.6M) | (83.0M) | (64.5M) | (67.8M) | |
| Net Income From Continuing Ops | (45.5M) | (94.0M) | (105.6M) | (82.5M) | (119.8M) | (113.8M) | |
| Ebit | (45.6M) | (94.5M) | (105.6M) | (82.5M) | (64.9M) | (68.1M) | |
| Research Development | 32.4M | 61.8M | 62.6M | 55.6M | 53.9M | 44.2M | |
| Ebitda | (45.6M) | (94.1M) | (105.2M) | (82.1M) | (64.5M) | (67.8M) | |
| Cost Of Revenue | 23K | 380K | 415K | 441K | 353K | 253.3K | |
| Total Operating Expenses | 45.6M | 94.5M | 105.6M | 83.0M | 74.5M | 66.1M | |
| Income Before Tax | (45.5M) | (94.0M) | (105.6M) | (82.5M) | (119.8M) | (113.8M) | |
| Total Other Income Expense Net | 69K | 505K | 34K | 442K | (55.2M) | (52.5M) | |
| Net Income Applicable To Common Shares | (16.5M) | (45.5M) | (94.0M) | (105.6M) | (95.0M) | (90.3M) | |
| Net Income | (45.4M) | (93.0M) | (104.6M) | (81.7M) | (119.8M) | (113.8M) | |
| Income Tax Expense | (116K) | (939K) | (970K) | (819K) | 185.1K | 252.2K | |
| Depreciation And Amortization | 23K | 380K | 415K | 441K | 354K | 371.7K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.